Diabetes

FDA grants second major patent for insulin delivery patch

Published in Obesity and Diabetes Week, January 12th, 2004

SpectRx, Inc., (SPRX) was granted a second significant patent for its SimpleChoicepatch insulin pump infusion set.

U.S. Patent No. 6,659,982 is the second patent issued for the new patch infusion technology. Additional patent applications are pending. The patch is for use with insulin pumps worn by people with diabetes to control their insulin levels.

The annual U.S. insulin pump infusion set market is approximately $270 million.

"We are very pleased with the news of the additional patent, and continue to be greatly encouraged by comments from pump users who have evaluated the patch," said Bill Arthur, SpectRx, Inc. president and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2004-01-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry